Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer

NCT00963872 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Lack of efficacy after interim analysis

Conditions

Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes

Interventions

DRUG: cyclophosphamide
DRUG: fludarabine phosphate
RADIATION: Total body irradiation
BIOLOGICAL: Umbilical cord blood unit with C3a fragment
BIOLOGICAL: Unmanipulated UCB Unit

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]